Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05164744 · ClinicalTrials.gov registry record
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
A clinical trial of COVID-19 and COVID-19 Respiratory Infection, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 510
- Enrollment target
- 3
- Study locations
NCT05164744 is a study of COVID-19 and COVID-19 Respiratory Infection that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 510 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05164744, a study of COVID-19 and COVID-19 Respiratory Infection, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 510 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac MRI
- DIAGNOSTIC_TEST Echocardiogram
- DIAGNOSTIC_TEST 6-minute walk test
- DIAGNOSTIC_TEST Questionnaire
Study Locations (3)
New York
- New York Presbyterian-Brooklyn Methodist Hospital - Brooklyn
- New York Presbyterian Queens - New York
- Weill Cornell Medicine/New-York Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2026-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05164744
The ClinicalTrials.gov registry entry for NCT05164744 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with COVID-19 appearing as the primary indexed condition, and to 4 interventions - of which Cardiac MRI is the first listed.
NCT05164744 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05164744 about?
NCT05164744 is a clinical study titled "Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors". The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify...
What is the current status of trial NCT05164744?
This trial is currently recruiting. The enrollment target is 510 participants. The study started on 2021-07-01. Estimated completion is 2026-07-30.
What conditions does trial NCT05164744 study?
This clinical trial studies the following conditions: COVID-19, COVID-19 Respiratory Infection, COVID-19 Pneumonia, COVID-19 Acute Respiratory Distress Syndrome, Coronavirus Disease 2019.
What interventions are being tested in trial NCT05164744?
The interventions under investigation include: Cardiac MRI (DIAGNOSTIC_TEST), Echocardiogram (DIAGNOSTIC_TEST), 6-minute walk test (DIAGNOSTIC_TEST), Questionnaire (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05164744?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05164744 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
-
Music Mindfulness Study 2a.
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.